Serina Therapeutics, Inc. (SER): Shareholders' Equity
-$37.0K
As of 2025-12-31
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$37.0K | n/m | 2026-03-25, Balance as of period end |
| 2024-12-31 | $641.0K | n/m | 2026-03-25, Balance as of period end |
| 2023-12-31 | -$32.29M | n/m | 2025-03-24, Balance as of period end |
| 2022-12-31 | -$17.21M | n/m | 2024-03-22, Balance as of period end |
| 2021-12-31 | -$11.83M | n/m | 2023-03-31, Balance as of period end |
| 2020-12-31 | -$5.12M | n/m | 2022-03-29, Balance as of period end |
| 2019-12-31 | $2.22M | -70.2% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $7.45M | +2.3% | 2020-03-31, Balance as of period end |
| 2017-12-31 | $7.28M | n/a | 2019-04-01, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$37.0K | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.14M | -57.0% |
| iBio, Inc. (IBIO) | 2026-06-30 | $85.71M | +476.0% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $14.86M | -49.8% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $7.83M | -76.1% |
| Clene Inc. (CLNN) | 2025-12-31 | -$17.59M | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $6.31M | +25.3% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$6.28M | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $24.10M | -64.8% |
Compare SER, BFRG, IBIO, LSTA side by side · Screen every company in Pharmaceutical Preparations ↗